Platform study of circulating tumor DNA–directed adjuvant chemotherapy in colon cancer (CLAUDIA Colon Cancer, KCSG CO22-12). A precision medicine trial leveraging tissue and blood-based tumor genomics ...
Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial. This is an ASCO Meeting Abstract from the 2024 ASCO ...
A long-standing debate over the most effective treatment for prevalent forms of colorectal cancer — the world’s third most diagnosed cancer — was finally settled in June 2022. The much-anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results